Opioids and Life Insurance: Risk of Abuse or Abuse of Risk (Slides)
Slides from this presentation, given at the 2018 ACSW Spring Meeting, have been posted at the Actuaries’ Club of the Southwest website.
Heroin – the Other Opioid
Currently heroin, cocaine, marijuana, prescription medications — specifically prescription opioids — and alcohol are recognized as the chief forms of substance abuse in our society. In this white paper, we continue our series examining the opioid epidemic and its significance for the life insurance industry.
Tobacco and Alcohol Underwriting in North America
We recently completed a survey of US and Canadian life insurers asking about underwriting practices and perceptions related to assessing tobacco/nicotine, alcohol and drug use. Over 100 carriers participated.
Drug Abuse Mortality in the Insured Population
Population data show that drug-related mortality rates have more than doubled since the beginning of the century. This statistic is troubling enough as it is, but it hides the fact that almost all the increase is due to opioids, which account for just over half of the deaths.
Opioid Epidemic – How Did We Get Here?
This paper seeks to understand the unique set of circumstances that led to the dramatic rise in opioid prescriptions over the last few decades, and provide a brief overview of the resultant morbidity and mortality for the insured population.
The Risk of Addiction With Sedative Prescriptions
In an earlier blog I outlined the health threat and addiction potential from non-prescription use of opioid painkillers. However, the problems do not stop with this class of drug. Sedative and hypnotic drugs also pose significant risk of physical and psychological dependence.
The Way to the Heart Is Up the Nose – Cardiovascular Effects of Cocaine (Gen Re)
The recreational use of cocaine was once thought to be the preserve of rock stars but tumbling prices and opportunities to buy it online have broadened its use.
Smoke and Mirrors: Marijuana Use and Underwriting
Most life insurers underwrite adult marijuana use as if it conferred the same relative mortality risk as cigarette smoking. Is this approach based on credible evidence or rather driven by long-standing misperceptions of the risk implications of marijuana consumption?